{
    "title": "109_hr5166",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Independent Pharmacy Protection Act \nof 2006''.\n\nSEC. 2. IMPROVING MEDICARE PRESCRIPTION DRUG PLAN PAYMENTS TO \n              PHARMACIES.\n\n    (a) In General.--Section 1860D-12(b) of the Social Security Act (42 \nU.S.C. 1395w-112(b)) is amended by adding at the end the following new \nparagraph:\n            ``(4) Payments to pharmacies.--\n                    ``(A) In general.--Each contract entered into with \n                a PDP sponsor under this section with respect to a \n                prescription drug plan offered by such sponsor shall \n                provide for the following:\n                            ``(i) Availability of direct deposit \n                        payments.--The option for any participating \n                        pharmacy to elect for the plan to make payments \n                        by direct deposits to the pharmacy for covered \n                        part D drugs dispensed through the pharmacy.\n                            ``(ii) Increased dispensing fee for generic \n                        drugs.--The payment of dispensing fees by the \n                        plan to each participating pharmacy for covered \n                        part D drugs dispensed through the \n                        participating pharmacy, in accordance with \n                        subparagraph (B).\n                            ``(iii) Payments within 10 days for certain \n                        pharmacies.--In the case of a participating \n                        pharmacy that is not part of a chain of \n                        pharmacies that consists of more than three \n                        pharmacies at different locations, payment with \n                        respect to any non-disputed claim (as defined \n                        in subparagraph (C)) for a covered part D drug \n                        dispensed through the pharmacy to be made by \n                        the plan to the pharmacy in full by a date that \n                        is not more than 10 days after the date on \n                        which the claim is received by the plan.\n                    ``(B) Payment of dispensing fees to encourage use \n                of generic drugs.--\n                            ``(i) In general.--For purposes of \n                        subparagraph (A)(ii) and subject to clauses \n                        (ii) and (iii), with respect to a generic \n                        covered part D drug that is therapeutically \n                        equivalent and bioequivalent to a brand name \n                        drug that is a covered part D drug dispensed \n                        through a participating pharmacy, the amount of \n                        the dispensing fee paid to the pharmacy for the \n                        generic covered part D drug shall be an amount \n                        that is at least 50 percent greater than the \n                        amount of the dispensing fee for the brand name \n                        drug.\n                            ``(ii) Cap on amount of dispensing fees for \n                        generic drugs.--For purposes of subclause (i), \n                        the amount of the dispensing fee paid to a \n                        participating pharmacy for a generic covered \n                        part D drug shall not be more than $10.\n                            ``(iii) Safe harbor for brand name drug \n                        dispensing fee amounts.--\n                                    ``(I) In general.--For purposes of \n                                clause (i) and subject to subclause \n                                (II), a prescription drug plan under \n                                this section shall not decrease the \n                                amount of the dispensing fee paid by \n                                the plan to a participating pharmacy \n                                for a brand name drug described in such \n                                clause to an amount that is less than \n                                the amount of the dispensing fee paid \n                                by such plan to such pharmacy for such \n                                drug on the date of the enactment of \n                                the `Independent Pharmacy Protection \n                                Act of 2006'.\n                                    ``(II) Exception.--The Secretary \n                                may waive the prohibition under \n                                subclause (I) with respect to a \n                                dispensing fee paid by a prescription \n                                drug plan for a brand name drug, as the \n                                Secretary determines appropriate.\n                    ``(C) Non-disputed claim defined.--For purposes of \n                subparagraph (A)(iii), a `non-disputed claim' means a \n                claim that has no defect or impropriety or particular \n                circumstance requiring special treatment that prevents \n                timely payment from being made under this part.''.\n    (b) Application to MA-PD Plans.--Section 1857(e) of such Act (42 \nU.S.C. 1395w-27(e)) is amended by adding at the end the following new \nparagraph:\n            ``(4) Incorporation of prescription drug plan contract \n        requirements for pharmacy payments.--The provisions of section \n        1860D-12(b)(4) shall apply to contracts with a Medicare \n        Advantage organization in the same manner as they apply to \n        contracts with a PDP sponsor offering a prescription drug plan \n        under part D.''.\n    (c) Effective Date.--The amendments made by this Act shall apply to \nplan years beginning on or after the date of the enactment of this Act."
}